FUNDAMENTALS · Fundamentals · TW Healthcare

Onyx Healthcare (6569) Fundamentals 2026 — P/E 27.2x, Revenue Analysis | SniperIQ

Onyx Healthcare (6569) is a TW-listed Healthcare company in Medical - Devices with a market capitalization of NT

.9B, trading at NT
01.00 on the TWO. This SniperIQ fundamentals page covers Onyx Healthcare's valuation (P/E 27.2x, P/B 2.5x), profitability (net margin 10.5%), revenue (NT
.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapNT
.9B
P/E (TTM)27.2x
Net Margin10.5%
Revenue (FY25)NT
.3B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Onyx Healthcare's market cap?

Onyx Healthcare (6569) has a market capitalization of approximately NT

.9B, trading at NT
01.00 on the TWO. Market cap moves with the live share price.

What is Onyx Healthcare's P/E ratio?

Onyx Healthcare's trailing twelve-month P/E ratio is 27.2x, with a price-to-book (P/B) of 2.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Onyx Healthcare?

Onyx Healthcare runs a net profit margin of 10.5%, a gross margin of 34.6%, and an operating margin of 6.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Onyx Healthcare generate?

Onyx Healthcare reported revenue of NT

.3B for fiscal year 2025, with net income of NT
12M and earnings per share (EPS) of 2.88. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Onyx Healthcare pay a dividend?

Onyx Healthcare offers a trailing dividend yield of about 3.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Onyx Healthcare financially healthy?

Onyx Healthcare carries a debt-to-equity ratio of 0.19x and a current ratio of 1.84x, with a market beta of 0.26. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Onyx Healthcare a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Onyx Healthcare (6569) the key facts are: market cap NT

.9B, P/E 27.2x, revenue NT
.3B, 52-week range 91.9-158. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Onyx Healthcare's full fundamentals live

Get Onyx Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.